Press release
Uveitis Market is Expected to Reach $17.78 Billion by 2031 - Novartis Inc, AbbVie, Johnson & Johnson Services Inc
Uveitis Market || 2024-2031
Uveitis is an inflammation of the uvea, the middle layer of the eye that includes the iris, ciliary body, and choroid. It can cause symptoms such as eye redness, pain, blurred vision, and light sensitivity. Uveitis can result from various causes, including infections, autoimmune disorders, and trauma. Prompt diagnosis and treatment are essential to prevent complications and preserve vision.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/uveitis-market
Key Development:
• On June 17, 2022, Sandoz, a provider of generic and biosimilar medicines, announced the European Medicines Agency (EMA) accepted its application for the high-concentration formulation of its biosimilar Hyrimoz (adalimumab) for regulatory review.
• The application includes all indications for Hyrimoz, such as rheumatoid arthritis, uveitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.
• This development aims to expand the treatment options available for these conditions.
• Sandoz continues to advance its biosimilar portfolio to meet growing patient needs.
Market Dynamics:
The global uveitis market is driven by several key factors, including the growing prevalence of ophthalmic disorders such as uveitis, glaucoma, and cataracts. Increased awareness initiatives, technological advancements, and the development of new drugs and products also contribute to market growth.
Pharmaceutical companies are expanding their product pipelines, and technological innovations are leading to the creation of novel treatments. Additionally, advancements in technology, an aging population, and increased investment in research and development are boosting market growth. The rise in ophthalmic disorders, including age-related macular degeneration (AMD), along with improvements in medical infrastructure in emerging markets, further supports the market's expansion.
Market Segment Analysis
By Uveitis Type: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Pan Uveitis
By Medications: Corticosteroids, Anti-Rheumatic Drugs, Cycloplegic-Mydriatic Drugs,Immunomodulatory Therapy, Biological Therapy, Anti-Viral Drugs, Others
By Medication Form: Eye Drops, Pills, Injections, Implants
By End-User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Get Customization in the report as per your requirements - https://www.datamintelligence.com/customize/uveitis-market
Major Key players
• Novartis AG
• AbbVie
• Johnson & Johnson Services, Inc.
• Amgen
• Alimera Sciences
• Bausch & Lomb Incorporated.
• Kiora Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• EyePoint Pharmaceuticals, Inc.
• Clearside Biomedical
*Note:
Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.
Related Reports:
Trauma Fixation Devices Market: https://datamintelligence.com/research-report/trauma-fixation-devices-market
Cardiac Ablation Devices Market: https://datamintelligence.com/research-report/cardiac-ablation-devices-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Market is Expected to Reach $17.78 Billion by 2031 - Novartis Inc, AbbVie, Johnson & Johnson Services Inc here
News-ID: 3653875 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Automatic Packaging Robot Market 2025 | Industry Developments, Fut …
Automatic Packaging Robot Market reached US$ 4.0 billion in 2023 and is projected to reach US$ 10.2 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031.
DataM Intelligence unveils its latest report on the "Automatic Packaging Robot Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and…
Human Augmentation Market 2025 | Industry Developments, Future Growth, Share & I …
The Human Augmentation Market reached US$ 252.6 billion in 2023 and is projected to reach US$ 780.7 billion by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031.
DataM Intelligence unveils its latest report on the "Human Augmentation Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging…
Learning Management System (LMS) Market 2025 | Industry Developments, Future Gro …
Learning Management System (LMS) Market reached US$ 18.7 billion in 2023 and is projected to reach US$ 67.2 billion by 2031, growing at a CAGR of 17.7% during the forecast period 2024-2031.
DataM Intelligence unveils its latest report on the "Learning Management System Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,…
Team Collaboration Tools Market 2025 | Industry Developments, Future Growth, Sha …
The Team Collaboration Tools Market reached US$ 23.3 billion in 2023 and is projected to reach US$ 62.8 billion by 2031, growing at a CAGR of 13.5% during the forecast period 2024-2031.
DataM Intelligence unveils its latest report on the "Team Collaboration Tools Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts,…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
